Gout

Annals of the Rheumatic Diseases

Volumn 58, Issue 10, 1999, Pages 611-616

  Perkins, P ^a   Jones, A C ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AZAPROPAZONE; BENZBROMARONE; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; SULFINPYRAZONE; URATE;

AGED; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; DIARRHEA; DIET RESTRICTION; DRUG EFFICACY; DRUG SAFETY; EDEMA; EOSINOPHILIA; FEVER; GASTROINTESTINAL HEMORRHAGE; GOUT; HUMAN; HYPERURICEMIA; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; TREATMENT INDICATION;

EID: 0032853192     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.10.611     Document Type: Article

References (50)

1. Grahame R, Scott JT. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970;29:461-8.
2. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu T-F. Preliminary criteria for the classification of the acute arthritis of primary gout Arthritis Rheum 1977;20:895-900.
3. Pascual E. The diagnosis of gout and CPPD crystal arthropathy. Br J Rheumatol 1996;35:306-3.
4. Schumacher HR. Crystal-induced arthritis: an overview, Am J Med 1996;100 (suppl 2A):46-52.
5. Lawry GV, Fan PT Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine 1988;67:335-43.
6. Wernick R, Winkler C, Camphell S. Tophi as the initial manifestation of gout. Arch Intern Med 1992;152:873-6.
7. Macfarlane DG, Dieppe PA. Diuretic-induced gout in elderly women. Br J Rheumatol 1985;24:155-7.
8. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricaemia risks and consequences in the Normative Ageing Study. Am J Med 1987;82:421-6.
9. Wolfe F, Cathey MA. The misdiagnosis of gout and hyperuricaemia. J Rheumatol 1991;18:1232-4.
10. Zell SC, Carmichael JM. Evaluation of allopurinol use in patients with gout. American Journal of Hospital Pharmacy 1989;46:1813-16.
11. Baer PA, Tenenhaum J, Fam AG, Little H. Coexistent septic and crystal arthritis. Report of four cases and literature review. J Rheumatol 1986;13:604-7.
12. Epstein JH, Zimmerman B, Ho G. Polyarticular septic arthritis. J Rheumatol 1986;13:1105-7.
13. Roseff R, Wohlgethan JR, Sipe JD, Canoso JJ. The acute phase response in gout. J Rheumatol 1987;14:974-7.
14. Goldenberg DL. Septic arthritis. Lancet 1998;351:197-202.
15. Gordon C, Swan A, Dieppe P. Detection of crystals in synovial Fluids by light microscopy: sensitivity and reliability. Ann Rheum Dis 1989;48:737-42.
16. McGill NW, York HF. Reproducibility of synovial fluid examination for crystals. Aust NZ J Med 1991;21:710-3.
17. Dieppe P, Campion G, Doherty M. Mixed crystal deposition. Rheum Dis Clin N Am 1988;14:415-26.
18. Pascual E, Tovar J, Ruiz MT. The ordinary light microscope: an appropriate tool for provisional detection and identification of crystals in synovial fluid. Ann Rheum Dis 1989;48:983-5.
19. Kerolus G, Clayburne G, Schumacher HR. Is it mandatory to examine synovial fluids promptly after arthrocentesis? Arthritis Rheum 1989;32:271-8.
20. Logan JA, Morrison F., McGill PE. Serum uric acid in acute gout. Ann Rhoum Dis 1997;56:696-7.
21. Schlesinger N, Baker DG, Schumacher HR Jr. Serum urate during bouts of acute gouty arthritis. J Rheumatol 1997;24:2265-6.
22. Weinberger A, Schumacher HR. Urate crystals in asymptomatic metatarsophalangeal joints. Ann Intern Med 1979; 91:56-7.
23. Agudelo CA, Weinberger A, Schumacher HR, Turner R, Molina J. Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints. Arthritis Rheum 1979;22:559-60.
24. Rouault T, Caldwell DS, Holmes EW. Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls. Arthritis Rheum 1982;25:209-12.
25. Bomalaski JS, Lluberas G, Schumacher HR. Monosodium urate crystals in the knee joints of patients with asymptomatic non-tophaccous gout. Arthritis Rheum 1986;29:1480-4.
26. Pascual E. Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 1991;34:141-5.
27. Gordon TP, Bertouch JV, Walsh BR, Brooks PM. Monosodium urate crystals in asymptomatic knee joints. J Rheumatol 1982;9:967-9.
28. Pascual E, Jovani V. A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout. Br J Rheurnatol 1995;34:724-6.
29. Becker MA. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout) Rheum Dis Clin N Am 1988;14:377-94.
30. Rozenberg S, Lang T, Laatar A, Koeger A-C, Orcel P, Bougerois P. Diversity of opinions on the management of gout in France. Rev Rhum 1996;63:255-61.
31. Bellarny N, Gilbert JR, Brooks PM, Emmerson BT, Campbell J. A survey of current prescribing practices of anti-inflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. J Rheumatol 1988; 15:1841-7.
32. Bellamy N, Brooks PM, Emmerson BT, Gilbert JR, Campbell J, McCredie M. A survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis in New South Wales and Queensland. Med J Aust 1989;151:531-7.
33. Stuart RA, Gow PJ, Bellamy N, Campbell J, Grigor R. A survey of current prescribing practices of anti-inflammatnry and urate-lowering drugs in gouty arthritis. NZ Med J 1991;104:115-17.
34. Wallace SL, Singer JZ. Review: systemic toxicity associated with the intravenous administration of colchicine- guide-lines for use. J Rheumatol 1988;15:495-9.
35. Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Aust NZ J Med 1987;17:301-4.
36. Groff GD, Franck WA, Raddatz DA, Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 1990;19:329-36.
37. Axelrod D, Preston S. Comparison of patenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988;31:803-5.
38. Yu TF, Gutman AB. Efficacy of colchicine prophylaxis in gout. Ann Intern Med 1961;55:179-92.
39. Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin N Am 1988;14:441-57.
40. Bull PW, Scott JT. Intermittent control of hyperuricaemia in the treatment of gout J Rheumatol 1989; 16:1246-8.
41. Van Lieshout-Zuidema MF, Breedveld FC. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout. J Rheumatol 1993;20:1383-5.
42. Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Arthritis Rheum 1986;29:82-7.
43. Fam AG, Lewtas J, Stein J, Paton TW. Desensitisation to allopurinol in patients with gout and cutaneous reactions. Am J Med 1992;93:299-302.
44. Lockard O, Harmon C, Nolph K, Irvin W. Allergic reaction to allopurinol with cross-reactivity to oxypurinol. Ann Intern Med 1976;85:333-5.
45. Relative safety of oral non-aspirin NSAIDs. Current problems in pharmacovigilance 1994;20:9-11.
46. Yu T-F, Gutman AB. Effect of allopurinol(4-hydroxypyrazolo(3,4-d)pyrimidine) on scrum and urinary uric acid in primary and secondary gout. Am J Med 1964; 37:885-98.
47. Delbarre F, Amor B, Auscher C, De Gery A. Treatment of gout with allopurinol. Ann Rheum Dis 1966;25:627-33.
48. Thompson GR, Duff IF, Robinson WD, Mikkelsen WM, Galindez H. Long term uricosuric therapy in gout. Arthritis Rheum 1962;5:384-96.
49. Paulus HE, Schlosstein LH, Grodfrey RG, Klinenberg JR, Bluestone R, Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated parents. Arthritis Rheum 1974;17:609-14.
50. Kot TV, Day RO, Brooks PM, preventing acute gout when starting therapy. Med J Aust 1993;159:182-4.